other_material
confidence high
sentiment positive
materiality 0.65
Indivior proposes redomiciliation to Delaware via new US parent IPI
Indivior Pharmaceuticals, Inc.
- Each Indivior PLC share exchanged for one share of new Delaware corporation Indivior Pharmaceuticals, Inc. (IPI).
- Timeline: shareholder circular mid-Nov 2025, EGM early Dec 2025, effective late Jan 2026.
- Scheme requires approval by 75% in value and majority in number of shareholders voting at EGM.
- No additional equity raised; IPI stock will trade on Nasdaq under symbol INDV.
- Proposed change aims to expand US capital markets presence and simplify governance.